Behçet's disease

(redirected from Behcet's disease)
Also found in: Dictionary, Thesaurus, Medical, Legal, Acronyms.
Related to Behcet's disease: Reiter's syndrome, Behcet's syndrome

Behçet's disease

[′bā‚chets di‚zēz]
(medicine)
Chronic disease of young adult males characterized by recurrent painful ulcers of the mouth and genitalia, inflammation of the irises, and joint pains.
References in periodicals archive ?
Diagnostic criteria of Behcet's disease research committee of Japan (revised in 2003) (2) Main symptoms Recurrent oral aphthous ulcers Skin lesions Ocular lesions Genital ulcers Additional Arthritis without deformity or sclerosis symptoms Epididymitis Ileocaecal ulceration Vascular CNS lesions Complete All 4 main symptoms present Incomplete 3 main symptoms or 2 main symptoms and 2 additional symptoms Suspicious Typical main symptoms, not fulfilling the criteria of incomplete Behcet's disease
Pay S, Simsek I, Erdem H, Dine A: Immunopathogenesis of Behcet's disease with special emphasize on the possible role of antigen presenting cells.
Behcet's disease is now recognized as a chronic condition that causes sores or ulcers in the mouth and on the genitals, and inflammation in parts of the eye.
Thalidomide was originally marketed as a wonder cure for morning sickness but once its awful side-effects became clear it was banned and has only recently emerged as a treatment for conditions such as Behcet's Disease.
A snapshot of the global therapeutic scenario for Behcet's Disease.
Myocarditis in Behcet's disease a case report and review of the literature.
Behcet's disease (BD), a multisystem inflammatory disease characterized mainly by recurrent attacks of oral aphthous ulcers, genital ulcers, uveitis, skin lesions and arthritis, is recognized as an unclassified vasculitis with a tendency towards thrombotic events (1).
33) Another report from Japan described a 47-year-old female with refractory Behcet's disease who responded to tocilizumab.
Moussatos said XOMA-052 is being developed to treat Type 2 Diabetes, Behcet's disease, cardiovascular diseases, and potentially other antiinflammatory indications.